The invention discloses a pharmaceutical composition for treating hyperosteogeny, the composition is composed of epimedium, 37, licorice, teasel, Qin Qiu, Rou Congrong, Wei Caulis Spatholobi, eucommia bark, cassia twig, Clematis chinensis, Fructus aurantii, Platycodon root, dried ginger thirteen Chinese medicinal materials. According to the traditional Chinese medicine formula of the invention, the powder, capsule, granule or tablet prepared by the extraction process of the traditional Chinese patent medicine are adopted. The medicine uses dispersing wind, removing dampness, promoting blood circulation and removing blood stasis, improving blood circulation, making circulation of Qi and blood normal, restoring bone health function, and contributing to relieving the pain of hyperosteogeny patients.
【技术实现步骤摘要】
【技术保护点】
一种用于治疗骨质增生的药用组合物,其特征在于它包括重量单位按份计的以下原料制成的: 淫洋藿55~90份 三七20~50份 甘草55~90份 川续断25~65份 秦艽25~65份 鸡血藤25~65份 煨杜仲55~90 份 肉苁蓉40~70份 桂枝40~70份 威灵仙40~70份 枳壳25~65份 桔梗55~90份 干姜20~50份。
【技术特征摘要】
【专利技术属性】
技术研发人员:伍荣林,
申请(专利权)人:北京天科仁祥医药科技有限公司,
类型:发明
国别省市:11[中国|北京]
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。